Agency for International Development (USA) : Questions médicales fréquentes
Nom anglais: United States Agency for International Development
Descriptor UI:D054702
Tree Number:N03.540.348.500.500.199
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Agency for International Development (USA) : Questions médicales les plus fréquentes",
"headline": "Agency for International Development (USA) : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Agency for International Development (USA) : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-08-04",
"dateModified": "2024-11-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Agency for International Development (USA)"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Agences gouvernementale américaines",
"url": "https://recherchemedicale.com/mesh/D037041",
"about": {
"@type": "MedicalCondition",
"name": "Agences gouvernementale américaines",
"code": {
"@type": "MedicalCode",
"code": "D037041",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.540.348.500.500"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Agency for International Development (USA)",
"alternateName": "United States Agency for International Development",
"code": {
"@type": "MedicalCode",
"code": "D054702",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Robbert J Duvivier",
"url": "https://recherchemedicale.com/author/Robbert%20J%20Duvivier",
"affiliation": {
"@type": "Organization",
"name": "Foundation for Advancement of International Medical Education and Research, Philadelphia, Pennsylvania."
}
},
{
"@type": "Person",
"name": "John R Boulet",
"url": "https://recherchemedicale.com/author/John%20R%20Boulet",
"affiliation": {
"@type": "Organization",
"name": "Foundation for Advancement of International Medical Education and Research, Philadelphia, Pennsylvania; jboulet@faimer.org."
}
},
{
"@type": "Person",
"name": "Jingjing Shang",
"url": "https://recherchemedicale.com/author/Jingjing%20Shang",
"affiliation": {
"@type": "Organization",
"name": "Center for Health Policy, Columbia University School of Nursing, 560 West 168th Street, Mail Code 6, New York 10032, NY, USA. Electronic address: js4032@cumc.columbia.edu."
}
},
{
"@type": "Person",
"name": "Ashley M Chastain",
"url": "https://recherchemedicale.com/author/Ashley%20M%20Chastain",
"affiliation": {
"@type": "Organization",
"name": "Center for Health Policy, Columbia University School of Nursing, 560 West 168th Street, Mail Code 6, New York 10032, NY, USA."
}
},
{
"@type": "Person",
"name": "Andrew W Dick",
"url": "https://recherchemedicale.com/author/Andrew%20W%20Dick",
"affiliation": {
"@type": "Organization",
"name": "The RAND Corporation, 20 Park Plaza, 9th Floor, Suite 920, Boston 02116, MA, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Demographics and mortality trends of valvular heart disease in older adults in the United States: Insights from CDC-wonder database 1999-2019.",
"datePublished": "2024-08-17",
"url": "https://recherchemedicale.com/article/39247722",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijcrp.2024.200321"
}
},
{
"@type": "ScholarlyArticle",
"name": "Utilization of Dental Care and Oral Health Outcomes in the United States: Results from the National Health and Nutrition Examination Survey (2017-2020).",
"datePublished": "2024-08-13",
"url": "https://recherchemedicale.com/article/39136435",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3290/j.ohpd.b5680746"
}
},
{
"@type": "ScholarlyArticle",
"name": "Trends in Heart Transplant Outcomes for Patients Over the Age of 70 Years in the United States: an Analysis of the Scientific Registry of Transplant Recipients Database.",
"datePublished": "2024-08-07",
"url": "https://recherchemedicale.com/article/39122221",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.healun.2024.08.001"
}
},
{
"@type": "ScholarlyArticle",
"name": "Risk of Small Intestine Cancer in Inflammatory Bowel Disease: A Propensity-Matched Study from a Large Multi-Center Database in the United States.",
"datePublished": "2024-07-25",
"url": "https://recherchemedicale.com/article/39051646",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.14309/ajg.0000000000002984"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hyperkalemia Incidence in Patients With Non-Dialysis Chronic Kidney Disease: A Large Retrospective Cohort Study From United States Clinical Care.",
"datePublished": "2024-07-25",
"url": "https://recherchemedicale.com/article/39328959",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.xkme.2024.100879"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Recherchemedicale.com",
"item": "https://recherchemedicale.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Organisations et économie des soins de santé",
"item": "https://recherchemedicale.com/mesh/D004472"
},
{
"@type": "ListItem",
"position": 3,
"name": "Organismes",
"item": "https://recherchemedicale.com/mesh/D009938"
},
{
"@type": "ListItem",
"position": 4,
"name": "Gouvernement",
"item": "https://recherchemedicale.com/mesh/D006076"
},
{
"@type": "ListItem",
"position": 5,
"name": "Agences gouvernementale américaines",
"item": "https://recherchemedicale.com/mesh/D037041"
},
{
"@type": "ListItem",
"position": 6,
"name": "Agency for International Development (USA)",
"item": "https://recherchemedicale.com/mesh/D054702"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Agency for International Development (USA) - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Agency for International Development (USA)",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-01-23",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Agency for International Development (USA)",
"description": "Comment évaluer l'impact de l'USAID sur la santé mondiale ?\nQuels outils utilise l'USAID pour le diagnostic des besoins ?\nComment l'USAID identifie-t-elle les maladies prioritaires ?\nQuels critères l'USAID utilise-t-elle pour le diagnostic des projets ?\nComment l'USAID évalue-t-elle les systèmes de santé ?",
"url": "https://recherchemedicale.com/mesh/D054702?page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Agency for International Development (USA)",
"description": "Quels symptômes l'USAID cible-t-elle dans ses programmes ?\nComment l'USAID aborde les symptômes de maladies tropicales ?\nQuels symptômes sont liés à l'accès à l'eau potable ?\nComment l'USAID traite-t-elle les symptômes de VIH/SIDA ?\nQuels symptômes sont observés dans les crises humanitaires ?",
"url": "https://recherchemedicale.com/mesh/D054702?page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Agency for International Development (USA)",
"description": "Quelles stratégies l'USAID utilise-t-elle pour la prévention des maladies ?\nComment l'USAID promeut-elle l'hygiène ?\nQuels programmes de prévention l'USAID met-elle en place pour le VIH ?\nComment l'USAID aborde-t-elle la prévention de la malnutrition ?\nQuelles initiatives l'USAID prend-elle pour la santé reproductive ?",
"url": "https://recherchemedicale.com/mesh/D054702?page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Agency for International Development (USA)",
"description": "Quels traitements l'USAID soutient-elle pour la tuberculose ?\nComment l'USAID aide-t-elle au traitement du paludisme ?\nQuels traitements l'USAID propose-t-elle pour la malnutrition ?\nComment l'USAID soutient-elle les soins maternels ?\nQuels traitements l'USAID offre-t-elle pour les maladies chroniques ?",
"url": "https://recherchemedicale.com/mesh/D054702?page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Agency for International Development (USA)",
"description": "Quelles complications l'USAID surveille-t-elle dans les soins de santé ?\nComment l'USAID gère-t-elle les complications de la malnutrition ?\nQuelles complications sont liées au VIH/SIDA ?\nComment l'USAID aborde-t-elle les complications des maladies tropicales ?\nQuelles complications l'USAID surveille-t-elle en cas de crise humanitaire ?",
"url": "https://recherchemedicale.com/mesh/D054702?page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Agency for International Development (USA)",
"description": "Quels facteurs de risque l'USAID identifie-t-elle pour la santé ?\nComment l'USAID évalue-t-elle les facteurs de risque environnementaux ?\nQuels comportements à risque l'USAID cible-t-elle ?\nComment l'USAID aborde-t-elle les facteurs de risque liés à la santé mentale ?\nQuels facteurs socio-économiques l'USAID considère-t-elle ?",
"url": "https://recherchemedicale.com/mesh/D054702?page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer l'impact de l'USAID sur la santé mondiale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'impact est évalué par des indicateurs de santé, des études de cas et des analyses de données."
}
},
{
"@type": "Question",
"name": "Quels outils utilise l'USAID pour le diagnostic des besoins ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID utilise des enquêtes, des analyses de données et des consultations communautaires."
}
},
{
"@type": "Question",
"name": "Comment l'USAID identifie-t-elle les maladies prioritaires ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID identifie les maladies prioritaires par des études épidémiologiques et des consultations."
}
},
{
"@type": "Question",
"name": "Quels critères l'USAID utilise-t-elle pour le diagnostic des projets ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent l'impact potentiel, la durabilité et l'alignement avec les besoins locaux."
}
},
{
"@type": "Question",
"name": "Comment l'USAID évalue-t-elle les systèmes de santé ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se fait par des audits, des analyses de performance et des enquêtes de satisfaction."
}
},
{
"@type": "Question",
"name": "Quels symptômes l'USAID cible-t-elle dans ses programmes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID cible des symptômes liés à la malnutrition, aux maladies infectieuses et aux soins maternels."
}
},
{
"@type": "Question",
"name": "Comment l'USAID aborde les symptômes de maladies tropicales ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID met en œuvre des programmes de prévention et de traitement pour les maladies tropicales."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à l'accès à l'eau potable ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des maladies diarrhéiques, des infections et des problèmes de santé liés à l'hygiène."
}
},
{
"@type": "Question",
"name": "Comment l'USAID traite-t-elle les symptômes de VIH/SIDA ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID fournit des traitements antirétroviraux et des programmes de sensibilisation et de prévention."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont observés dans les crises humanitaires ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent la malnutrition, les maladies infectieuses et les traumatismes psychologiques."
}
},
{
"@type": "Question",
"name": "Quelles stratégies l'USAID utilise-t-elle pour la prévention des maladies ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID utilise l'éducation, la vaccination et l'amélioration des infrastructures sanitaires."
}
},
{
"@type": "Question",
"name": "Comment l'USAID promeut-elle l'hygiène ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID promeut l'hygiène par des campagnes de sensibilisation et des programmes d'accès à l'eau."
}
},
{
"@type": "Question",
"name": "Quels programmes de prévention l'USAID met-elle en place pour le VIH ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID met en place des programmes de sensibilisation, de dépistage et de traitement préventif."
}
},
{
"@type": "Question",
"name": "Comment l'USAID aborde-t-elle la prévention de la malnutrition ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID aborde la malnutrition par des programmes d'éducation nutritionnelle et de soutien alimentaire."
}
},
{
"@type": "Question",
"name": "Quelles initiatives l'USAID prend-elle pour la santé reproductive ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID prend des initiatives pour l'accès à la contraception et l'éducation à la santé reproductive."
}
},
{
"@type": "Question",
"name": "Quels traitements l'USAID soutient-elle pour la tuberculose ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID soutient des programmes de dépistage, de traitement et de sensibilisation à la tuberculose."
}
},
{
"@type": "Question",
"name": "Comment l'USAID aide-t-elle au traitement du paludisme ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID fournit des moustiquaires, des médicaments et des programmes de prévention du paludisme."
}
},
{
"@type": "Question",
"name": "Quels traitements l'USAID propose-t-elle pour la malnutrition ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID propose des suppléments nutritionnels et des programmes d'éducation alimentaire."
}
},
{
"@type": "Question",
"name": "Comment l'USAID soutient-elle les soins maternels ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID soutient la formation des sages-femmes et l'accès aux soins prénatals et postnatals."
}
},
{
"@type": "Question",
"name": "Quels traitements l'USAID offre-t-elle pour les maladies chroniques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID offre des programmes de gestion des maladies chroniques et d'éducation à la santé."
}
},
{
"@type": "Question",
"name": "Quelles complications l'USAID surveille-t-elle dans les soins de santé ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID surveille les complications liées aux maladies infectieuses et aux soins maternels."
}
},
{
"@type": "Question",
"name": "Comment l'USAID gère-t-elle les complications de la malnutrition ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID gère les complications par des traitements médicaux et des programmes de réhabilitation nutritionnelle."
}
},
{
"@type": "Question",
"name": "Quelles complications sont liées au VIH/SIDA ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent les infections opportunistes et les maladies chroniques associées."
}
},
{
"@type": "Question",
"name": "Comment l'USAID aborde-t-elle les complications des maladies tropicales ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID aborde les complications par des traitements ciblés et des programmes de prévention."
}
},
{
"@type": "Question",
"name": "Quelles complications l'USAID surveille-t-elle en cas de crise humanitaire ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID surveille les complications telles que la malnutrition aiguë et les maladies infectieuses."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque l'USAID identifie-t-elle pour la santé ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID identifie des facteurs tels que la pauvreté, l'accès limité aux soins et l'éducation insuffisante."
}
},
{
"@type": "Question",
"name": "Comment l'USAID évalue-t-elle les facteurs de risque environnementaux ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID évalue les facteurs environnementaux par des études d'impact et des analyses de données."
}
},
{
"@type": "Question",
"name": "Quels comportements à risque l'USAID cible-t-elle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID cible des comportements tels que la consommation de drogues, le tabagisme et les rapports sexuels non protégés."
}
},
{
"@type": "Question",
"name": "Comment l'USAID aborde-t-elle les facteurs de risque liés à la santé mentale ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID aborde ces facteurs par des programmes de sensibilisation et d'accès aux soins psychologiques."
}
},
{
"@type": "Question",
"name": "Quels facteurs socio-économiques l'USAID considère-t-elle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID considère des facteurs comme l'éducation, l'emploi et l'accès aux services de santé."
}
}
]
}
]
}
Valvular heart disease (VHD) represents a spectrum of cardiac conditions, including valvular stenosis, valvular regurgitation, or mixed lesions affecting single or multiple valves. The severity of VHD...
To evaluate temporal trends in mortality associated with VHD in the elderly U.S population between 1999 and 2019....
We utilized the CDC WONDER database for VHD mortality in adults ≥75 from 1999 to 2019, using ICD-10 codes. Age-adjusted mortality rates (AAMR) per 100,000 people with associated annual percentage chan...
A total of 666,765 VHD deaths in older adults from 1999 to 2019 was identified, with an initial decline in AAMR until 2007 with an APC: 0.62, 95 % CI (-1.66-0.33), stability until 2014, and a signific...
Our study showed a decline in U.S. VHD mortality from 1999 to 2019 but found persistent disparities by gender, race, age, region, and VHD type. Targeted policies for prevention and early diagnosis are...
This analysis aims to evaluate the association between the time since and reason for a patient's last dental appointment across clinical oral health outcomes....
We used data from the 2017-2020 National Health and Nutrition Examination Survey (NHANES), a cross-sectional, nationally-representative survey of noninstitutionalized US adults. The predictors were th...
Two-thirds of the US population had a dental appointment within a year, while nearly 44 million individuals did not visit a dentist for the last three years. The odds of having teeth with untreated co...
Recent, routine dental appointments are associated with improved oral health outcomes. The outcomes reiterate how social determinants of health impact access to oral health care and oral health outcom...
Patients of advanced age are often considered to be poor candidates for heart transplant (HT). As the U.S. population continues to age, it is important for clinicians to understand how best to select ...
This was a retrospective analysis of the U.S. Scientific Registry of Transplant Recipients data from 2006 to August 2022 in adult recipients. Patients were excluded if they were multiorgan transplant,...
Recipients ≥70 had a one-year survival of 87.5%, compared to 91.1% for <60, and 88.4% for 60-69 years (p<0.001). Survival improved numerically, but not significantly, as transplant eras progressed for...
Overall, HT outcomes are excellent for carefully selected patients ≥70 years, and transplanting patients in this age cohort can be considered....
The risk of small bowel cancer (SBC) in inflammatory bowel disease (IBD) is unclear. We compared the recent trends of SBC in patients with IBD and stratified them based on disease type....
We used TriNetX database to access the electronic health records for patients with IBD, ulcerative colitis (UC) and Crohn's disease (CD) from 2005-2024. We used propensity score matching to compare th...
From 2010-2024, there was an increasing trend of diagnosed SBC in patients with IBD, with an Average Annual Percentage Change (AAPC) of 3.2% (P<0.001). Patients with CD (aHR = 4.83; 95% CI: 3.58 - 6.5...
Both patients with CD and, interestingly, UC had an elevated risk for developing SBC compared to the general population....
Estimates of the incidence of hyperkalemia in patients with chronic kidney disease (CKD) vary widely. Our objective was to estimate hyperkalemia incidence in patients with CKD from routine clinical ca...
Retrospective cohort study....
1,771,900 patients with stage 1-4 CKD identified from the US Optum De-Identified electronic health records database....
Impaired kidney damage or function level at baseline based on urinary albumin-creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR), respectively, and selected patient subgroups....
Hyperkalemia: 2 elevated serum potassium values (≥5.5 mmol/L) from the inpatient setting (2-24 hours apart) or outpatient setting (maximum 7 days apart), or 1 elevated serum potassium value plus pharm...
Incidence rates of hyperkalemia were calculated. Estimates were stratified by UACR and eGFR level at baseline and patient subgroups....
Over a mean follow-up of 3.9 years, the incidence of hyperkalemia was 3.37 events/100 person-years (95% confidence intervals, 3.36-3.38). Higher incidence rates were observed with increased UACR and l...
Potential misclassification of variables from possible medical coding errors; potential data incompleteness issues if patients received care at institutions not included in Optum....
Hyperkalemia is a frequent occurrence in CKD, particularly in patients with T2DM, heart failure, or prescribed sMRAs, indicating the need for regular serum potassium and UACR monitoring in this patien...
Existing research on medical cannabis patients has often overlooked those younger than 21. This study aimed to detail the frequency and rate of pediatric medical cannabis patients in the US using a la...
Utilizing Leafwell Patient Database data from 2019 to mid-2023, we described demographics and qualifying conditions, employing descriptive statistics and χ2 tests to discern differences between minors...
Analyzing 13,855 patients, 5.7% were minors and 94.3% were young adults. Anxiety emerged as the primary self-reported condition for both groups, yet differences were seen for other conditions. Differe...
This study underscores demographic distinctions between minor-aged medical cannabis patients and young adults. There is a need for comprehensive clinical research addressing efficacy, safety, and tail...
Optimal gestational weight change (GWC) is little known among pregnant women with gestational diabetes mellitus (GDM)....
This study aimed to explore the optimal GWC ranges for women with GDM and validate these ranges compared to the Institute of Medicine (IOM) guidelines....
A population-based cohort study using natality data from the National Center for Health Statistics (NCHS) in the United States included 1,338,460 mother-infant pairs with GDM from 2014 to 2020. Poisso...
The severity-weighted composite outcome had a U-shaped or a J-shaped relationship with GWC across body mass index (BMI) categories. The GDM targets were 14.1-20.3 kg, 9.0-17.0 kg, 4.8-13.8 kg, -0.8-10...
The IOM guidelines are generally applicable for women with GDM, with the exception of women with moderate and severe obesity. The optimal GWC ranges for women with GDM and moderate to severe obesity m...
Studies on the association between serum lead levels and parathyroid function in adolescents are lacking. Therefore, in this study, we elucidated the possible association between blood lead levels (BL...
In this study, information from the database of the National Health and Nutrition Examination Survey was utilized. The study included 3919 participants from survey cycles between 2003-2004 and 2005-20...
Multivariable linear regression analysis revealed that every 1 μg/dL increase in BLLs was associated with 0.67 pg/mL increase in PTH (β = 0.67, 95% CI: 0.16-1.18, p < 0.01). However, sex-stratified su...
In adolescents in the United States, BLLs are positively correlated with PTH, particularly in males....
Children with special health care needs (CSHCN)-ie, children who are at increased risk for, or currently manage, persistent physical and mental health conditions-require more health care resources tha...
Religiousness and spirituality (R/S) are associated with lower morbidity and mortality, yet the physiological mechanisms underlying these associations are under-studied. Chronic inflammation is a plau...
The purpose of the present study was to examine associations between multiple R/S dimensions and two markers of chronic inflammation, interleukin-6 (IL-6) and C-reactive protein (CRP)....
In this cross-sectional study, data came from biological subsamples of two cohorts from the Midlife in the United States (MIDUS) Study (combined N = 2,118). Predictors include six R/S measures (servic...
Older adults, women (vs. men), non-White (vs. White) adults, those with higher BMIs, current smokers, and those not meeting physical activity guidelines had significantly higher IL-6 and CRP. In fully...
Many dimensions of R/S may be health protective for adults given their associations with lower levels of chronic inflammation. Findings underscore the importance of examining multiple dimensions of R/...